Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.450
-0.040 (-1.15%)
At close: Oct 2, 2026, 4:00 PM EDT
3.300
-0.150 (-4.35%)
After-hours: Oct 2, 2026, 4:10 PM EDT
Alterity Therapeutics Employees
Alterity Therapeutics had 11 employees as of June 30, 2026. The number of employees increased by 2 or 22.22% compared to the previous year.
Employees
11
Change (1Y)
2
Growth (1Y)
22.22%
Revenue / Employee
$227,038
Profits / Employee
-$1,471,712
Market Cap
58.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 11 | 2 | 22.22% |
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Alps Group | 93 |
| Clene | 79 |
| MindWalk Holdings | 77 |
| Xilio Therapeutics | 76 |
| Connect Biopharma Holdings | 64 |
| Mereo BioPharma Group | 39 |
| eXoZymes | 32 |
| Boundless Bio | 28 |
ATHE News
- 17 days ago - Alterity Therapeutics management to meet virtually with Lake Street - TheFly
- 17 days ago - Alterity Therapeutics management to meet virtually with Lake Street - TheFly
- 17 days ago - Alterity Therapeutics initiated with a Buy at Lake Street - TheFly
- 21 days ago - Alterity Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics Annual report: H2 2026 - Filings
- 6 weeks ago - Alterity Therapeutics granted new patent for ATH434 - TheFly
- 7 weeks ago - Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434 - GlobeNewsWire